| scholarly article | Q13442814 |
| P50 | author | William R. Markesbery | Q56850445 |
| Jeffrey Keller | Q73027689 | ||
| P2093 | author name string | Feng Li | |
| Qinghua Chen | |||
| Qunxing Ding | |||
| P2860 | cites work | Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. | Q52011735 |
| Aging, memory, and mild cognitive impairment. | Q52044622 | ||
| Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain. | Q53366814 | ||
| Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease | Q24685592 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Mild cognitive impairment: clinical characterization and outcome | Q28140626 | ||
| Ribosome assembly in eukaryotes | Q29615231 | ||
| Pre-ribosomes on the road from the nucleolus to the cytoplasm | Q29616319 | ||
| An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease | Q31041277 | ||
| Mild cognitive impairment represents early-stage Alzheimer disease | Q33938635 | ||
| Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron | Q34402849 | ||
| Evidence of increased oxidative damage in subjects with mild cognitive impairment. | Q34410726 | ||
| Ubiquitin depletion as a key mediator of toxicity by translational inhibitors | Q34986792 | ||
| Molecular network and functional implications of macromolecular tRNA synthetase complex | Q35102816 | ||
| Pathology and pathways of Alzheimer's disease with an update on new developments in treatment. | Q35151999 | ||
| Mild cognitive impairment: directions for future research | Q35206270 | ||
| Ribosome biogenesis: of knobs and RNA processing | Q35761799 | ||
| Selective translational control and nonspecific posttranscriptional regulation of ribosomal protein gene expression during development and regeneration of rat liver | Q36815033 | ||
| A hamster temperature-sensitive alanyl-tRNA synthetase mutant causes degradation of cell-cycle related proteins and apoptosis. | Q40582708 | ||
| Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival. | Q40758147 | ||
| Mammalian aminoacyl-tRNA synthetases. | Q40996465 | ||
| Alzheimer's disease-associated reduction of polysomal mRNA translation | Q42075712 | ||
| Mild cognitive impairment in the elderly: predictors of dementia | Q43742864 | ||
| Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease | Q44224817 | ||
| Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice | Q44587906 | ||
| Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures. | Q45166155 | ||
| RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. | Q48270446 | ||
| Preparation of a cell-free extract from rat brain which can initiate protein synthesis in vitro | Q48301448 | ||
| Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease | Q48419985 | ||
| Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex | Q48632716 | ||
| Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. | Q50917440 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 40 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 9171-9175 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Ribosome dysfunction is an early event in Alzheimer's disease | |
| P478 | volume | 25 |
| Q33815578 | A DNA damage-activated checkpoint kinase phosphorylates tau and enhances tau-induced neurodegeneration |
| Q36725255 | A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury |
| Q24329154 | APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in the rRNA quality control process. |
| Q37349329 | Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain |
| Q50279747 | Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome. |
| Q36336723 | Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease. |
| Q40955570 | Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model |
| Q46572523 | Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo |
| Q64110774 | Amyloid β Induces Early Changes in the Ribosomal Machinery, Cytoskeletal Organization and Oxidative Phosphorylation in Retinal Photoreceptor Cells |
| Q34680525 | An assay for RNA oxidation induced abasic sites using the Aldehyde Reactive Probe |
| Q57289144 | Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases |
| Q37710290 | Battle against RNA oxidation: molecular mechanisms for reducing oxidized RNA to protect cells |
| Q57286208 | CASS: A distributed network clustering algorithm based on structure similarity for large-scale network |
| Q38900020 | Cell-penetrating peptides with intracellular organelle targeting |
| Q44921042 | Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression |
| Q42732353 | Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. |
| Q36114529 | Characterization of RNA damage under oxidative stress in Escherichia coli |
| Q37365439 | DNA methylation, a hand behind neurodegenerative diseases |
| Q53748072 | Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease. |
| Q84581239 | Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation |
| Q42368761 | Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach |
| Q37808258 | Do ribosomopathies explain some cases of common variable immunodeficiency? |
| Q57807691 | Dosage effects of human ribosomal genes (rDNA) in health and disease |
| Q84523946 | Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation |
| Q38820585 | Dual roles of DNA repair enzymes in RNA biology/post-transcriptional control |
| Q34512386 | Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression |
| Q64078574 | Emerging Role of the Nucleolar Stress Response in Autophagy |
| Q26863209 | Emerging roles of the neuronal nucleolus |
| Q27026649 | Emerging roles of the nucleolus in regulating the DNA damage response: the noncanonical DNA repair enzyme APE1/Ref-1 as a paradigmatical example |
| Q31028501 | Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease |
| Q39090345 | Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation |
| Q91894190 | Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment |
| Q36761675 | Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models |
| Q24646192 | Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice |
| Q60912540 | Gene expression, proteome and calcium signaling alterations in immortalized hippocampal astrocytes from an Alzheimer's disease mouse model |
| Q28559519 | Genes of susceptibility to early neurodegenerative changes in the rat retina and brain: analysis by means of congenic strains |
| Q92055113 | Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer's disease |
| Q64229924 | Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice |
| Q39348564 | Global translational responses to oxidative stress impact upon multiple levels of protein synthesis. |
| Q35208328 | Hook proteins: association with Alzheimer pathology and regulatory role of hook3 in amyloid beta generation |
| Q92795149 | How do cells cope with RNA damage and its consequences? |
| Q24316168 | Human polynucleotide phosphorylase reduces oxidative RNA damage and protects HeLa cell against oxidative stress |
| Q36939900 | Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain |
| Q42630478 | Identification of molecular alterations in leukocytes from gene expression profiles of peripheral whole blood of Alzheimer's disease |
| Q36175360 | Impaired APP activity and altered Tau splicing in embryonic stem cell-derived astrocytes obtained from an APPsw transgenic minipig |
| Q64259145 | Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging |
| Q33897525 | Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease |
| Q33403405 | Independent component analysis of Alzheimer's DNA microarray gene expression data |
| Q42706017 | Inhibition of nucleolar transcription as a trigger for neuronal apoptosis |
| Q28082431 | Insights into the regulation of neuronal viability by nucleophosmin/B23 |
| Q39287034 | Intermediate filament transcription in astrocytes is repressed by proteasome inhibition. |
| Q34795190 | Interplay between oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease |
| Q33674631 | Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease |
| Q33558839 | Intrusion of a DNA repair protein in the RNome world: is this the beginning of a new era? |
| Q34545547 | Involvement of oxidative stress in Alzheimer disease |
| Q47144715 | In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology |
| Q48122655 | Lessons in the study of Alzheimer's disease: a tribute to Dr. William R. Markesbery. |
| Q30637868 | Limited effects of an eIF2αS51A allele on neurological impairments in the 5xFAD mouse model of Alzheimer's disease |
| Q64936587 | Lost in Translation: Evidence for Protein Synthesis Deficits in ALS/FTD and Related Neurodegenerative Diseases. |
| Q39359828 | Luteolin reduces zinc-induced tau phosphorylation at Ser262/356 in an ROS-dependent manner in SH-SY5Y cells |
| Q92129095 | Magnesium Is a Key Player in Neuronal Maturation and Neuropathology |
| Q42127225 | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism |
| Q36879018 | Markers of oxidant stress that are clinically relevant in aging and age-related disease |
| Q33358054 | Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS |
| Q91982308 | Mitochondrial Dysfunction and Stress Responses in Alzheimer's Disease |
| Q37462278 | Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches |
| Q59854882 | Molecular properties underlying regional vulnerability to Alzheimer's disease pathology |
| Q55469742 | Non-coding RNA-linked epigenetic regulation in cardiac hypertrophy. |
| Q41763844 | Non-random distribution of methyl-CpG sites and non-CpG methylation in the human rDNA promoter identified by next generation bisulfite sequencing |
| Q36872209 | Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease |
| Q26769950 | Nuclear Tau and Its Potential Role in Alzheimer's Disease |
| Q37965702 | Nuclear and mitochondrial DNA oxidation in Alzheimer's disease |
| Q36681098 | Nucleolar PARP-1 Expression Is Decreased in Alzheimer's Disease: Consequences for Epigenetic Regulation of rDNA and Cognition. |
| Q42031023 | Nucleolar disruption and apoptosis are distinct neuronal responses to etoposide-induced DNA damage |
| Q38016374 | Oxidative damage to RNA in aging and neurodegenerative disorders |
| Q43092721 | Oxidative damage to RNA in neurodegenerative diseases |
| Q34441389 | Oxidative damage to RNA: mechanisms, consequences, and diseases |
| Q53386725 | Oxidative inactivation of the proteasome in Alzheimer's disease. |
| Q52580699 | Oxidative stress alters neuronal RNA- and protein-synthesis: Implications for neural viability. |
| Q33555956 | Oxidative stress and mitochondrial dysfunction in Alzheimer's disease |
| Q47197769 | Oxidative stress damages rRNA inside the ribosome and differentially affects the catalytic center |
| Q37616153 | Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail? |
| Q36091445 | Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy |
| Q37238146 | Oxidatively modified RNA in mild cognitive impairment |
| Q35286714 | Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain |
| Q33639885 | Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis |
| Q35576065 | Oxidized messenger RNA induces translation errors |
| Q47648801 | Oxygen Supplementation Improves Protein Milieu Supportive of Protein Synthesis and Antioxidant Function in the Cortex of Alzheimer's Disease Model Mice-a Quantitative Proteomic Study. |
| Q34245014 | Parkinson's disease DJ-1 L166P alters rRNA biogenesis by exclusion of TTRAP from the nucleolus and sequestration into cytoplasmic aggregates via TRAF6 |
| Q36480214 | Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis |
| Q36654505 | Pathophysiological mechanisms for actions of the neurotrophins |
| Q37910243 | Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before. |
| Q37230045 | Polynucleotide phosphorylase protects Escherichia coli against oxidative stress |
| Q51263731 | Proapoptotic Requirement of Ribosomal Protein L11 in Ribosomal Stress-Challenged Cortical Neurons. |
| Q21144321 | Promoter-wide hypermethylation of the ribosomal RNA gene promoter in the suicide brain |
| Q37295665 | Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study |
| Q33415671 | Proteomics analysis of protein expression and specific protein oxidation in human papillomavirus transformed keratinocytes upon UVB irradiation |
| Q46194651 | Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells |
| Q38828283 | Quality control of chemically damaged RNA. |
| Q42840227 | Quantification of oxidized levels of specific RNA species using an aldehyde reactive probe |
| Q36840564 | RNA in brain disease: no longer just "the messenger in the middle". |
| Q37369990 | RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia |
| Q35056112 | RNA oxidation catalyzed by cytochrome c leads to its depurination and cross-linking, which may facilitate cytochrome c release from mitochondria |
| Q37228654 | RNA oxidation: a contributing factor or an epiphenomenon in the process of neurodegeneration |
| Q83002527 | RNA under attack: cellular handling of RNA damage |
| Q98771874 | Recent Advances: Molecular Mechanism of RNA Oxidation and Its Role in Various Diseases |
| Q61799924 | Regional protein expression in human Alzheimer's brain correlates with disease severity |
| Q36674660 | Requirement of Neuronal Ribosome Synthesis for Growth and Maintenance of the Dendritic Tree |
| Q35118239 | Ribosomal DNA transcription in the dorsal raphe nucleus is increased in residual but not in paranoid schizophrenia |
| Q64098798 | Risk of cognition alteration and emotional frailty via circulating transcriptome in treatment naïve head and neck squamous cell cancer patients |
| Q35675884 | Role of Oxidative RNA Damage in Chronic-Degenerative Diseases |
| Q30394816 | Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease |
| Q42148660 | Sequestration of Ribosome during Protein Aggregate Formation: Contribution of ribosomal RNA |
| Q37083453 | Sublethal RNA oxidation as a mechanism for neurodegenerative disease |
| Q59811719 | Systematic Analysis and Biomarker Study for Alzheimer's Disease |
| Q91645657 | TAR Cloning: Perspectives for Functional Genomics, Biomedicine, and Biotechnology |
| Q37789848 | TOR on the brain. |
| Q33980306 | Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease |
| Q64273568 | Tau drives translational selectivity by interacting with ribosomal proteins |
| Q58801555 | The Involvement of Aβ42 and Tau in Nucleolar and Protein Synthesis Machinery Dysfunction |
| Q92062254 | The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) |
| Q35783379 | The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons |
| Q34714815 | The effects of aging vs. α7 nAChR subunit deficiency on the mouse brain transcriptome: aging beats the deficiency |
| Q28279644 | The functions of RPS19 and their relationship to Diamond-Blackfan anemia: a review |
| Q37964897 | The neuropathological profile of mild cognitive impairment (MCI): a systematic review. |
| Q94511999 | Tyr-Trp administration facilitates brain norepinephrine metabolism and ameliorates a short-term memory deficit in a mouse model of Alzheimer's disease |
| Q36607342 | Ubiquitin proteasome system as a pharmacological target in neurodegeneration. |
| Q88727534 | Upregulation of PSMB8 and cathepsins in the human brains of dementia with Lewy bodies |
| Q56975629 | Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer's Disease and Reconstruction of Relevant Biological Mechanisms |
| Q38101227 | When stable RNA becomes unstable: the degradation of ribosomes in bacteria and beyond. |
| Q28308319 | mTOR-dependent signalling in Alzheimer's disease |
Search more.